AbbVie has submitted regulatory applications to both the FDA and the European Medicines Agency for Rinvoq (upadacitinib) to treat adult patients with giant cell arteritis (GCA) https://t.co/LqRcm2FEFV https://t.co/XEjjSNnOGt
Links:
AbbVie Submits Applications for Rinvoq for Giant Cell Arteritis
https://buff.ly/4bCIs4Q
Jul-15-2024
